Skip to search.
 TSX Down 0.87% TSX Ventures Down 0.21%

Merck & Co. Inc. (MRK)

-NYSE
51.59 Down 1.06(2.01%) Sep 4, 4:01PM EDT
|After Hours : 51.61 Up 0.02 (0.04%) Sep 4, 7:51PM EDT
Add to Portfolio
Prev Close:52.65
Open:52.10
Bid:51.69 x 100
Ask:51.84 x 400
1y Target Est:65.29
Beta:0.580286
Next Earnings Date:27-Oct-15MRK Earnings announcement
Day's Range:51.18 - 52.24
52wk Range:45.69 - 63.62
Volume:14,491,288
Avg Vol (3m):10,371,600
Market Cap:145.31B
P/E (ttm):15.07
EPS (ttm):3.42
Div & Yield:1.80 (3.40%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
MRKDown 2.01%145.31B
GSKDown 2.29%95.93B
PFEDown 1.63%193.47B

Key Statistics

Forward P/E (1 yr):13.51
P/S (ttm):3.68
Ex-Dividend Date:11-Sep-15

Analysts

Annual EPS Est (Dec-15) :3.51
Quarterly EPS Est (Sep-15) :0.92
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):2.12

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Merck & Co., Inc. provides health care solutions worldwide. The company offer therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infec... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback